55 Participants Needed

iParent2Parent Support Program for Solid Organ Transplant Parents

SJ
IS
SB
Overseen BySophie Bui, BHSc
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: The Hospital for Sick Children
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial does not specify whether you need to stop taking your current medications. It focuses on a mentorship program for parents, so it's unlikely to require changes to your medication.

What data supports the effectiveness of the iParent2Parent Support Program treatment for parents of children undergoing solid organ transplants?

The iParent2Parent Support Program may be effective based on similar interventions like the myFAMI program, which showed feasibility and acceptability in helping families manage post-transplant challenges. Although no significant differences were found, outcomes were positive, suggesting that support programs can improve coping and family quality of life.12345

How is the iParent2Parent Support Program different from other treatments for parents of children undergoing solid organ transplants?

The iParent2Parent Support Program is unique because it focuses on providing emotional and psychosocial support to parents of children undergoing solid organ transplants, addressing the specific stresses and challenges they face during the transplant process. Unlike medical treatments that target the physical aspects of transplantation, this program aims to improve family functioning and reduce stress, which can positively impact the overall health outcomes for both the child and the family.24567

What is the purpose of this trial?

The iParent2Parent (iP2P) program is a new, innovative virtual mentorship program that will connect parents one-to-one with other parents of pediatric solid organ transplant (SOT) recipients who are trained to offer vital peer support and mentorship. Parents of children who received a SOT at The Hospital for Sick Children will be invited to participate as mentors and mentees (randomized into the iP2P or control group). The iP2P program can decrease feelings of isolation, improve mental health and have a long-term positive impact on patient health. This research will increase our understanding of one-to-one peer support and leverage eHealth technologies to improve the access to and acceptability of parent peer support interventions.

Research Team

SJ

Samantha J Anthony, PhD

Principal Investigator

The Hospital for Sick Children

Eligibility Criteria

This trial is for parents of children under 18 who had a solid organ transplant at least two months ago, or under 21 if they're one year post-transplant. They need to speak English and have access to WhatsApp on a device. To be mentors, they must be recommended by their child's healthcare team.

Inclusion Criteria

I am a parent of a child who had an organ transplant over a year ago, nominated to be a mentor, and can use WhatsApp.

Exclusion Criteria

Non-English speaking.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

iParent2Parent Program

Participants engage in a virtual mentorship program connecting parents of pediatric solid organ transplant recipients for peer support

12 weeks
Virtual interactions

Follow-up

Participants are monitored for engagement and outcomes after the intervention

up to 1 year

Treatment Details

Interventions

  • iParent2Parent Program
Trial Overview The iParent2Parent Program connects parents of pediatric SOT recipients with trained parent mentors through virtual mentorship. The study will assess whether this program helps reduce isolation and improve mental health among these parents.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: iParent2Parent ProgramExperimental Treatment1 Intervention
Group II: Standard of Care Waitlist Control GroupActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

The Hospital for Sick Children

Lead Sponsor

Trials
724
Recruited
6,969,000+

Findings from Research

Fathers of children undergoing solid organ or bone marrow transplantation reported lower levels of parenting stress and family conflict compared to normative data, suggesting they may cope better than expected in these challenging situations.
Despite lower stress and conflict, these fathers expressed greater concerns about family finances and reported more limitations in family activities, indicating that financial and activity-related challenges remain significant issues for families in pediatric transplantation.
Perceptions of parenting stress and family relations by fathers of children evaluated for organ transplantation.Rodrigue, JR., MacNaughton, K., Hoffmann, RG., et al.[2006]
Parents of children who received solid organ transplants face significant challenges during the transition from hospital to home, which evolves over time into three distinct phases: 'getting back to normal' at 3 weeks, 'becoming routine' at 3 months, and 'facing a future' at 6 months.
Nurses play a crucial role in supporting these families by preparing them to manage complex care needs, helping to build their confidence and knowledge for effective post-discharge care.
Parents' perspectives on caring for children after solid organ transplant.Lerret, SM., Johnson, NL., Haglund, KA.[2019]
The myFAMI mobile health intervention was found to be feasible and acceptable for families of pediatric solid organ transplant recipients, with 81% of participants completing the program for at least 24 out of 30 days.
While there were no significant differences in primary outcomes, the intervention showed positive trends in coping, family quality of life, and self-efficacy, indicating potential benefits for future post-discharge support.
Feasibility and Acceptability of a mHealth Self-Management Intervention for Pediatric Transplant Families.Lerret, SM., Schiffman, R., White-Traut, R., et al.[2023]

References

Perceptions of parenting stress and family relations by fathers of children evaluated for organ transplantation. [2006]
Parents' perspectives on caring for children after solid organ transplant. [2019]
Feasibility and Acceptability of a mHealth Self-Management Intervention for Pediatric Transplant Families. [2023]
Parents' quality of life and family functioning in pediatric organ transplantation. [2017]
Psychosocial issues in pediatric organ transplantation: the parents' perspective. [2004]
A systematic review of parent and family functioning in pediatric solid organ transplant populations. [2022]
Mothers of children evaluated for transplantation: stress, coping resources, and perceptions of family functioning. [2006]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security